gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cancer of Rectum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avallone, A; Ciliberto, G; Delrio, P; Fusco, R; Granata, V; Pecori, B; Petrillo, A; Petrillo, M; Sansone, M; Tatangelo, F | 1 |
| Chan, Q; Gu, J; Khong, PL; Law, W; Liu, RK; Wang, S; Wu, EX; Zhang, J | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of Rectum
| Article | Year |
|---|---|
Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC.
Topics: Adenocarcinoma; Adult; Aged; Chemoradiotherapy, Adjuvant; Contrast Media; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Prospective Studies; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2015 |
Dynamic contrast-enhanced MRI of primary rectal cancer: quantitative correlation with positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |